Shenyan Gu

Dr. Shenyan Gu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2014 in Toxins
Verified
Journal Article
Open access
PDF file
GYGuorui Yao
Guorui Yao
KLKwangkook Lee
Kwangkook Lee
SGShenyan Gu
Shenyan Gu
KLKwok Ho Lam
Kwok Ho Lam
RJRongsheng Jin
Rongsheng Jin
Botulinum neurotoxins (BoNTs) are potent bacterial toxins. The high oral toxicity of BoNTs is largely attributed to the progenitor toxin complex (PTC), which is assembled from BoNT and nontoxic neurotoxin-associated proteins (NAPs) that are produced together with BoNT in bacteria. Here, we performed ex vivo studies to examine binding of the highly homogeneous recombinant NAPs to mouse small intestine. We also carried out the first comprehensive glycan array screening with the hemagglutinin (HA) component of NAPs. Our data confirmed that intestinal binding of the PTC is partly mediated by the HA moiety through multivalent interactions between HA and host carbohydrates. The specific HA-carbohydrate recognition could be inhibited by receptor-mimicking saccharides.

19 October 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
DKDaniel Knowland
Daniel Knowland
SGShenyan Gu
Shenyan Gu
WEWilliam A. Eckert
William A. Eckert
GDG. Brent Dawe
G. Brent Dawe
JMJose A. Matta
Jose A. Matta
DBDavid S. Bredt
David S. Bredt
The α6β4 nicotinic acetylcholine receptor (nAChR) is enriched in dorsal root ganglia neurons and is an attractive non-opioid therapeutic target for pain. However, difficulty expressing human α6β4 receptors in recombinant systems has precluded drug discovery. Here, genome-wide screening identified accessory proteins that enable reconstitution of human α6β4 nAChRs. BARP, an auxiliary subunit of voltage-dependent calcium channels, promoted α6β4 surface expression while IRE1α, an unfolded protein response sensor, enhanced α6β4 receptor assembly. Effects on α6β4 involve BARP’s N-terminal region and IRE1α’s splicing of XBP1 mRNA. Furthermore, clinical efficacy of nicotinic agents in relieving neuropathic pain best correlated with their activity on α6β4. Finally, BARP-knockout, but not NACHO-knockout mice lacked nicotine-induced antiallodynia, highlighting the functional importance of α6β4 in pain. These results identify roles for IRE1α and BARP in neurotransmitter receptor assembly and unlock drug discovery for the previously elusive α6β4 receptor.

1 January 2015 in Toxicon
Verified
Journal Article
Closed access
KLKwangkook Lee
Kwangkook Lee
XZXiaofen Zhong
Xiaofen Zhong
SGShenyan Gu
Shenyan Gu
AKAnna Magdalena Kruel
Anna Magdalena Kruel
MDMartin B. Dorner
Martin B. Dorner
RJRongsheng Jin
Rongsheng Jin